Robert E. Hull - 22 Feb 2022 Form 4 Insider Report for HEALTHCARE REALTY TRUST INC (HR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Feb 2022, 15:34:33 UTC
Prior SEC filing
04 Jan 2022
Next SEC filing
22 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew E. Loope, by power of attorney

Key filing fact

Robert E. Hull filed Form 4 for HEALTHCARE REALTY TRUST INC (HR) on 23 Feb 2022.

Key facts

  • This page summarizes Robert E. Hull's Form 4 filing for HEALTHCARE REALTY TRUST INC (HR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Feb 2022, 15:34.

Change

  • Previous filing in this sequence was filed on 04 Jan 2022.
  • Current net transaction value: +$440,970.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HR transaction

Common Stock

Award

Transaction value
$440,970
Shares
+14,294
Change %
+8.3%
Price
$30.85*
Shares after
185,739
Date
22 Feb 2022
Ownership
Direct
Footnotes
F1
HR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16
Date
22 Feb 2022
Ownership
by child 2
HR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16
Date
22 Feb 2022
Ownership
by child 3
HR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16
Date
22 Feb 2022
Ownership
by child 1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The grant is in the form of restricted shares subject to a five-year cliff vesting period that were awarded pursuant to the Company's Amended and Restated Executive Incentive Plan for Company performance achieved in 2021. The plan required final measurement of performance upon completion of the Company's Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 22, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .